Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.

Saved in:
Bibliographic Details
Title: Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.
Authors: Ndashimye, Emmanuel1,2 (AUTHOR), Avino, Mariano3 (AUTHOR), Olabode, Abayomi S3 (AUTHOR), Poon, Art F Y1,3,4 (AUTHOR), Gibson, Richard M1 (AUTHOR), Li, Yue1 (AUTHOR), Meadows, Adam1 (AUTHOR), Tan, Christine1 (AUTHOR), Reyes, Paul S1 (AUTHOR), Kityo, Cissy M5 (AUTHOR), Kyeyune, Fred2 (AUTHOR), Nankya, Immaculate2 (AUTHOR), Quiñones-Mateu, Miguel E6 (AUTHOR), Arts, Eric J1 (AUTHOR) earts@uwo.ca
Source: Journal of Antimicrobial Chemotherapy (JAC). Dec2020, Vol. 75 Issue 12, p3525-3533. 9p.
Database: Environment Complete
Description
ISSN:03057453
DOI:10.1093/jac/dkaa355